These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 2146697

  • 1. A placebo- and imipramine-controlled study of paroxetine.
    Cohn JB, Crowder JE, Wilcox CS, Ryan PJ.
    Psychopharmacol Bull; 1990; 26(2):185-9. PubMed ID: 2146697
    [Abstract] [Full Text] [Related]

  • 2. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients.
    Fabre LF.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():40-3. PubMed ID: 1531823
    [Abstract] [Full Text] [Related]

  • 3. The safety and efficacy of paroxetine compared with placebo in a double-blind trial of depressed outpatients.
    Claghorn JL.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():33-5. PubMed ID: 1531821
    [Abstract] [Full Text] [Related]

  • 4. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 5. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP, Boyer WF.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():44-7. PubMed ID: 1531824
    [Abstract] [Full Text] [Related]

  • 6. Paroxetine versus placebo: a double-blind comparison in depressed patients.
    Claghorn JL, Kiev A, Rickels K, Smith WT, Dunbar GC.
    J Clin Psychiatry; 1992 Dec; 53(12):434-8. PubMed ID: 1487471
    [Abstract] [Full Text] [Related]

  • 7. A double-blind comparison of paroxetine, imipramine, and placebo in major depression.
    Shrivastava RK, Shrivastava SH, Overweg N, Blumhardt CL.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():48-51. PubMed ID: 1531825
    [Abstract] [Full Text] [Related]

  • 8. Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression.
    Dunner DL, Cohn JB, Walshe T, Cohn CK, Feighner JP, Fieve RR, Halikas JP, Hartford JT, Hearst ED, Settle EC.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():57-60. PubMed ID: 1531827
    [Abstract] [Full Text] [Related]

  • 9. Paroxetine in major depression: a double-blind trial with imipramine and placebo.
    Cohn JB, Wilcox CS.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():52-6. PubMed ID: 1531826
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerance of femoxetine and imipramine in the treatment of depressive states. A randomized, double-blind study.
    Suominen J, Tamminen T, Elosuo R, Manniche PM.
    Pharmacopsychiatry; 1988 Sep; 21(5):238-44. PubMed ID: 3067246
    [Abstract] [Full Text] [Related]

  • 11. A double-blind, placebo-controlled study of paroxetine in depressed outpatients.
    Kiev A.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():27-9. PubMed ID: 1531818
    [Abstract] [Full Text] [Related]

  • 12. The short- and long-term efficacy of paroxetine HCl: A. Data from a 6-week double-blind parallel design trial vs. imipramine and placebo.
    Peselow ED, Filippi AM, Goodnick P, Barouche F, Fieve RR.
    Psychopharmacol Bull; 1989 Feb; 25(2):267-71. PubMed ID: 2532373
    [No Abstract] [Full Text] [Related]

  • 13. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.
    Chouinard G, Saxena BM, Nair NP, Kutcher SP, Bakish D, Bradwejn J, Kennedy SH, Sharma V, Remick RA, Kukha-Mohamad SA.
    Clin Neuropharmacol; 1993 Feb; 16 Suppl 2():S51-4. PubMed ID: 8313397
    [Abstract] [Full Text] [Related]

  • 14. A double-blind comparison of gepirone extended release, imipramine, and placebo in the treatment of outpatient major depression.
    Feiger AD.
    Psychopharmacol Bull; 1996 Feb; 32(4):659-65. PubMed ID: 8993088
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [Abstract] [Full Text] [Related]

  • 16. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
    Schweizer E, Feighner J, Mandos LA, Rickels K.
    J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
    [Abstract] [Full Text] [Related]

  • 17. The efficacy and safety of paroxetine compared with placebo in outpatients with major depression.
    Rickels K, Amsterdam J, Clary C, Fox I, Schweizer E, Weise C.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():30-2. PubMed ID: 1531820
    [Abstract] [Full Text] [Related]

  • 18. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder.
    Smith WT, Glaudin V, Panagides J, Gilvary E.
    Psychopharmacol Bull; 1990 Feb; 26(2):191-6. PubMed ID: 2236455
    [Abstract] [Full Text] [Related]

  • 19. A controlled study of mianserin in moderately to severely depressed outpatients.
    Carman JS, Ahdieh H, Wyatt-Knowles E, Warga E, Panagides J.
    Psychopharmacol Bull; 1991 Feb; 27(2):135-9. PubMed ID: 1924659
    [Abstract] [Full Text] [Related]

  • 20. A placebo-controlled trial of paroxetine in the treatment of major depression.
    Smith WT, Glaudin V.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():36-9. PubMed ID: 1531822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.